Heparin-induced thrombocytopenia without thrombocytopenia in a patient with essential thrombocythemia [9]

American Journal of Hematology

Volumn 65, Issue 4, 2000, Pages 331-332

  Houston, Donald S ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DANAPAROID; HEPARIN; WARFARIN;

AGED; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; HUMAN; LETTER; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOCYTE COUNT; THROMBOCYTHEMIA; THROMBOCYTOPENIA; VEIN THROMBOSIS;

AGED; ANTICOAGULANTS; FEMALE; HEPARIN; HUMANS; THROMBOCYTOPENIA; THROMBOCYTOSIS; VENOUS THROMBOSIS;

EID: 0033750311     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-8652(200012)65:4<331::AID-AJH23>3.0.CO;2-2     Document Type: Letter

References (5)

1. Heparin-induced thrombocytopenia: Towards consensus
2. The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia
3. Heparin-induced thrombocytopenia
4. Platelet hyperactivation in patients with essential thrombocythemia is not associated with vascular endothelial cell damage as judged by the level of plasma thrombomodulin, protein S, PAI-1, t-PA, and vWF
5. Cranial sinus thrombosis associated with essential thrombocythemia followed by heparin-associated thrombocytopenia